BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 26619282)

  • 1. Effect of Temporal Resolution on Diagnostic Performance of Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate.
    Othman AE; Falkner F; Weiss J; Kruck S; Grimm R; Martirosian P; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 May; 51(5):290-6. PubMed ID: 26619282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of CAIPIRINHA-Dixon-TWIST-VIBE for dynamic contrast-enhanced MRI of the prostate.
    Othman AE; Martirosian P; Schraml C; Taron J; Weiss J; Bier G; Schwentner C; Nickel D; Bamberg F; Kramer U; Nikolaou K; Notohamiprodjo M
    Eur J Radiol; 2015 Nov; 84(11):2110-6. PubMed ID: 26321493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different population-averaged arterial-input-functions in dynamic contrast-enhanced MRI of the prostate: Effects on pharmacokinetic parameters and their diagnostic performance.
    Othman AE; Falkner F; Kessler DE; Martirosian P; Weiss J; Kruck S; Kaufmann S; Grimm R; Kramer U; Nikolaou K; Notohamiprodjo M
    Magn Reson Imaging; 2016 May; 34(4):496-501. PubMed ID: 26708031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast enhanced MRI of the prostate: comparison of gadobutrol and Gd-DTPA.
    Durmus T; Vollnberg B; Schwenke C; Kilic E; Huppertz A; Taupitz M; Franiel T
    Rofo; 2013 Sep; 185(9):862-8. PubMed ID: 23888476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Resolution Diffusion-Weighted Imaging Improves the Diagnostic Accuracy of Dynamic Contrast-Enhanced Sinonasal Magnetic Resonance Imaging.
    Wang F; Sha Y; Zhao M; Wan H; Zhang F; Cheng Y; Tang W
    J Comput Assist Tomogr; 2017; 41(2):199-205. PubMed ID: 27560026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.
    Baur AD; Maxeiner A; Franiel T; Kilic E; Huppertz A; Schwenke C; Hamm B; Durmus T
    Invest Radiol; 2014 Jun; 49(6):411-20. PubMed ID: 24598440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients.
    Yuan Q; Costa DN; Sénégas J; Xi Y; Wiethoff AJ; Rofsky NM; Roehrborn C; Lenkinski RE; Pedrosa I
    J Magn Reson Imaging; 2017 Mar; 45(3):908-916. PubMed ID: 27442039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced and diffusion-weighted MR imaging in the characterisation of small, non-palpable solid testicular tumours.
    Manganaro L; Saldari M; Pozza C; Vinci V; Gianfrilli D; Greco E; Franco G; Sergi ME; Scialpi M; Catalano C; Isidori AM
    Eur Radiol; 2018 Feb; 28(2):554-564. PubMed ID: 28856410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
    Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
    Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
    Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R
    Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population net benefit of prostate MRI with high spatiotemporal resolution contrast-enhanced imaging: A decision curve analysis.
    Prabhu V; Rosenkrantz AB; Otazo R; Sodickson DK; Kang SK
    J Magn Reson Imaging; 2019 May; 49(5):1400-1408. PubMed ID: 30629317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
    Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
    J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
    Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
    AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compressed Sensing for Breast MRI: Resolving the Trade-Off Between Spatial and Temporal Resolution.
    Vreemann S; Rodriguez-Ruiz A; Nickel D; Heacock L; Appelman L; van Zelst J; Karssemeijer N; Weiland E; Maas M; Moy L; Kiefer B; Mann RM
    Invest Radiol; 2017 Oct; 52(10):574-582. PubMed ID: 28463932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization.
    Cristel G; Esposito A; Damascelli A; Briganti A; Ambrosi A; Brembilla G; Brunetti L; Antunes S; Freschi M; Montorsi F; Del Maschio A; De Cobelli F
    Eur J Radiol; 2019 Sep; 118():51-57. PubMed ID: 31439258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved detection of hypervascular liver lesions with CAIPIRINHA-Dixon-TWIST-volume-interpolated breath-hold examination.
    Kazmierczak PM; Theisen D; Thierfelder KM; Sommer WH; Reiser MF; Notohamiprodjo M; Nikolaou K
    Invest Radiol; 2015 Mar; 50(3):153-60. PubMed ID: 25478742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compressed Sensing Radial Sampling MRI of Prostate Perfusion: Utility for Detection of Prostate Cancer.
    Winkel DJ; Heye TJ; Benz MR; Glessgen CG; Wetterauer C; Bubendorf L; Block TK; Boll DT
    Radiology; 2019 Mar; 290(3):702-708. PubMed ID: 30599102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of qualitative, semi-quantitative, and quantitative analyses of dynamic contrast-enhanced magnet resonance imaging on prostate cancer detection.
    Ziayee F; Ullrich T; Blondin D; Irmer H; Arsov C; Antoch G; Quentin M; Schimmöller L
    PLoS One; 2021; 16(4):e0249532. PubMed ID: 33819295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
    Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
    Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.